Revised SPC: Ofev (nintedanib) 100 mg soft capsules

This product is now licensed for the treatment of other chronic fibrosing interstitial lung diseases with a progressive phenotype in adults. Information relating to this new indication has been added to various sections of the SPC.

electronic Medicines compendium